New β-lactamases in gram-negative bacteria: Diversity and impact on the selection of antimicrobial therapy

Clinical Infectious Diseases

Volumn 32, Issue 7, 2001, Pages 1085-1089

  Bush, K ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZTREONAM; BACTERIAL ENZYME; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CARBAPENEM; CARBENICILLIN; CEFEPIME; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CEPHALOSPORINASE; CLAVULANIC ACID; CLOXACILLIN; OXACILLIN; PENICILLINASE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATE; ENZYME ANALYSIS; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS;

EID: 0035311003     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/319610     Document Type: Article

References (33)

1. Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics
2. How β-lactamases have driven pharmaceutical drug discovery: From mechanistic knowledge to clinical circumvention
3. A functional classification scheme for β-lactamases and its correlation with molecular structure
4. Carbapenem-hydrolyzing β-lactamases
5. Inhibitor-resistant TEM β-lactamases: Phenotypic, genetic and biochemical characteristics
6. OXA-16, a further extended-spectrum variant of OXA-10 β-lactamase, from two Pseudomonas aeruginosa isolates
7. Induction of β-lactamase by various β-lactam antibiotics in Enterobacter cloacae
8. The effects on β-lactam susceptibility of phenotypic induction and genotypic derepression of β-lactamase synthesis
9. Selection and characterization of cefepime-resistant gram-negative bacteria
10. Imipenem- and meropenem-resistant mutants of Enterobacter cloacae and Proteus rettgeri lack porins
11. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein
12. Novel plasmid-mediated β-lactamase (MIR-1) conferring resistance to oxyimino- and α-methoxy β-lactams in clinical isolates of Klebsiella pneumoniae
13. Gene sequence and biochemical characterization of FOX-1 from Klebsiella pneumoniae, a new AmpC-type plasmid-mediated β-lactamase with two molecular variants
14. A clavulanate-resistant K. pneumoniae clinical isolate encoding plasmid-mediated TEM-2-like and FOX-5 β-lactamases
15. Transferable imipenem resistance in Pseudomonas aeruginosa
16. IMP) in gram-negative rods resistant to broad-spectrum β-lactams
17. Characterization of the metallo-β-lactamase determinant of Acinetobacter baumannii AC-54/97 reveals the existence of bla(IMP) allelic variants carried by gene cassettes of different phylogeny
18. VIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate
19. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France
20. An overview of the kinetic parameters of class B β-lactamases
21. Sporadic emergence of Klebsiella pneumoniae strains resistant to cefepime and cefpirome in Greek hospitals
22. Multiplicity of TEM-derived βlactamases from Klebsiella pneumoniae strains isolated at the same hospital and relationships between the responsible plasmids
23. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins
24. CTX-M-5, a novel cefotaximehydrolyzing β-lactamase from an outbreak of Salmonella typhimurium in Latvia
25. Nucleotide sequence and characterization of a novel cefotaxime-hydrolyzing β-lactamase (CTX-M-10) isolated in Spain
26. Concurrent outbreaks of extended-spectrum β-lactamase-producing organisms of the family Enterobacteriaceae in a Warsaw hospital
27. Multiply resistant Klebsiella pneumoniae from two Chicago hospitals: Identification of the extended spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing β-lactamases in a single isolate
28. In vitro activities of various βlactam antimicrobial agents against clinical isolates of Escherichia coli and Klebsiella species resistant to oxyimino cephalosporins
29. Use of microdilution panels with and without β-lactamase inhibitors as a phenotypic test for βlactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens
30. Characterization of the extended-spectrum β-lactamase reference strain, Klebsiella pneumoniae K6 (ATCC 700603), which produces the novel enzyme SHV-18
31. Membrane permeability modifications are involved in antibiotic resistance in Klebsiella pneumoniae
32. Contributions of the AmpC βlactamase and the AcrAB multidrug efflux system in intrinsic resistance of Escherichia coli K-12 to β-lactams